Literature DB >> 15526370

Effects of dermatan sulfate derivatives on platelet surface P-selectin expression and protein C activity in blood of inflammatory bowel disease patients.

Sheng-Li Ji1, Hai-Yan Du, Yan-Qing Chi, Hui-Fei Cui, Ji-Chao Cao, Mei-Yu Geng, Hua-Shi Guan.   

Abstract

AIM: To investigate the effect of dermatan sulfate (DS) derivatives on platelet surface P-selectin expression and blood activated protein C (APC) activity in patients with inflammatory bowel disease (IBD), and to clarity the anti-inflammatory mechanism of DS derivatives.
METHODS: Dermatan sulfate (DS) was sulfated with chlorosulfonic acid to prepare polysulfated dermatan sulfate (PSDS). The major disaccharides of DS and PSDS were determined by 1H nuclear magnetic resonance spectroscopy (1H-NMR) and 13C-NMR. Both DS and PSDS were depolymerized with hydrogen peroxide. The fragments were separated by gel filtration chromatography. The effects of DS derivatives on P-selectin expression were assayed by ELISA method, and blood APC activity was assayed by the synthetic chromogenic substrate method.
RESULTS: The major disaccharides of DS and PSDS were IdoA-1-3-GalNAc-4-SO3 and IdoA-2SO3-1-3-GalNAc4, 6-diSO3, respectively. Compared with the adenosine diphosphate stimulated group and IBD control group, DS and its derivatives all had significant inhibitory effects on P-selectin expression (P<0.01), but there was no difference between DS-derived oligosaccharides (DSOSs) and PSDS-derived oligosaccharides (PSDSOSs). The experiments on APC activity showed that DS and its derivatives all enhanced APC activity. The most active DSOS was the one with a relative molecular weight (Mr) of 4,825, which enhanced the APC activity from 106.5+/-11.5% to 181.8+/-22.3% (P<0.01). With the decrease of Mr, the activity of DSOSs decreased gradually. The effect of PSDS on APC activity enhancement was more significant than that of DS, and the APC activity was raised to 205.2+/-22.1% (P<0.01). All the PSDSOSs were more active than DSOSs on the basis of comparable Mr. With the decrease of Mr, the activity of PSDSOSs increased gradually, and the most active PSDSOS was PSDSOS3 with Mr of 2,749, which enhanced the APC activity to 331.2+/-27.8% (P<0.01), then the activity of PSDSOSs decreased gradually.
CONCLUSION: DS and its derivatives can significantly inhibit P-selectin expression on platelet surface, but the effect has no correlation with DS molecular mass and sulfation. The effect of DS or its derivatives on APC activity at molecular level involves complex mechanisms that depend on the molecular mass, the degree of sulfation, and the heterogeneous composition of DS. On the same molecular size, the higher the degree of DS sulfation, the more significant the effect on enhancing APC activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526370      PMCID: PMC4576232          DOI: 10.3748/wjg.v10.i23.3485

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  43 in total

1.  Development and validation of a size exclusion chromatography method for determination of molecular masses and molecular mass distribution in low molecular weight heparin.

Authors:  H I Kristensen; E M Tromborg; J R Nielsen; J I Nielsen; K B Johansen; P B Ostergaard
Journal:  Thromb Res       Date:  1991-10-15       Impact factor: 3.944

2.  Glycosaminoglycans affect the action of human plasma kallikrein on kininogen hydrolysis and inflammation.

Authors:  Andrezza J Gozzo; Viviane A Nunes; Adriana K Carmona; Helena B Nader; Carl Peter von Dietrich; Vera L F Silveira; Kazuaki Shimamoto; Nobuyuki Ura; Misako U Sampaio; Claudio A M Sampaio; Mariana S Araújo
Journal:  Int Immunopharmacol       Date:  2002-12       Impact factor: 4.932

3.  Vascular complications of inflammatory bowel disease.

Authors:  R W Talbot; J Heppell; R R Dozois; R W Beart
Journal:  Mayo Clin Proc       Date:  1986-02       Impact factor: 7.616

4.  Elongated dermatan sulphate in post-inflammatory healing skin distributes among collagen fibrils separated by enlarged interfibrillar gaps.

Authors:  K Kuwaba; M Kobayashi; Y Nomura; S Irie; Y Koyama
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

5.  Inflammatory bowel disease promotes venous thrombosis earlier in life.

Authors:  O Grip; P J Svensson; S Lindgren
Journal:  Scand J Gastroenterol       Date:  2000-06       Impact factor: 2.423

6.  Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke.

Authors:  M Shibata; S R Kumar; A Amar; J A Fernandez; F Hofman; J H Griffin; B V Zlokovic
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

7.  Inherited disorders of coagulation appear to protect against inflammatory bowel disease.

Authors:  N P Thompson; A J Wakefield; R E Pounder
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

8.  Paradoxical response to heparin in 10 patients with ulcerative colitis.

Authors:  P R Gaffney; C T Doyle; A Gaffney; J Hogan; D P Hayes; P Annis
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

9.  Structure and contribution to the heparin cofactor II-mediated inhibition of thrombin of naturally oversulphated sequences of dermatan sulphate.

Authors:  G Mascellani; L Liverani; P Bianchini; B Parma; G Torri; A Bisio; M Guerrini; B Casu
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

10.  Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants.

Authors:  Simone Saibeni; Marco Cattaneo; Maurizio Vecchi; Maddalena Loredana Zighetti; Anna Lecchi; Rossana Lombardi; Gianmichele Meucci; Luisa Spina; Roberto de Franchis
Journal:  Am J Gastroenterol       Date:  2003-01       Impact factor: 10.864

View more
  1 in total

1.  Inhibitory activity of Sargassum hemiphyllum sulfated polysaccharide in arachidonic acid-induced animal models of inflammation.

Authors:  Pai-An Hwang; Yu-Lan Hung; Shih-Yung Chien
Journal:  J Food Drug Anal       Date:  2014-10-29       Impact factor: 6.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.